Aeterna, Ferrer, Schering sales and marketing update

Ferrer received exclusive commercialization and distribution rights to AEL's Neovastat (AE-941) oral

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE